We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smiths Medical Acquires Respiratory Device Firm

By HospiMedica staff writers
Posted on 13 Jul 2004
Print article
In a move to expand its portfolio of respiratory products, Smiths Medical (London, UK) has acquired DHD Healthcare (Wampsville, NY, USA) for U.S.$55 million.

DHD's products are used to care for the respiratory needs of patients in a variety of therapeutic and critical care applications. The company had sales of U.S.$21.2 million over the past 12 months. Smiths acquired DHD from Riverside Capital (Cleveland, OH, USA). Smiths Medical is one of the four operating divisions of the Smiths Group plc, which designs and manufactures critical safety systems and products, including medical devices.

"DHD's world class respiratory products will complement and extend the Smiths Medical airway range with high-growth, novel respiratory care devices,” said Lawrence Kinet, managing director of Smiths Medical.





Related Links:
Smiths Medical
DHD Healthcare
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Facet Fixation System
ZYFUSE
New
Pediatric Stretcher
PS410

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.